id	domain	url
ajlm-1017	doi.org	https://doi.org/10.4102/ajlm.v9i2.1017
ajlm-1017	doi.org	https://doi.org/10.1016/s0140-6736(17)31224-2
ajlm-1017	doi.org	https://doi.org/10.1016/s1473-3099(16)30518-7
ajlm-1017	doi.org	https://doi.org/10.5055/ajdm.2015.0196
ajlm-1017	www.finddx.org	https://www.finddx.org/wp-content/uploads/2018/05/find_outbreak-strategy_web.pdf
ajlm-1017	doi.org	https://doi.org/10.1136/bmjgh-2018-001112
ajlm-1017	doi.org	https://doi.org/10.1038/nbt.3215
ajlm-1017	www.who.int	http://www.who.int/blueprint/priority-diseases/key-action/ebola-additional-documents/en
ajlm-1017	www.fda.gov	https://www.fda.gov/medicaldevices/safety/emergencysituations/ucm161496.htm#ebola
ajlm-1017	doi.org	https://doi.org/10.1128/jcm.01972-17
ajlm-1017	doi.org	https://doi.org/10.1038/d41586-019-00212-y
ajlm-1017	doi.org	https://doi.org/10.3201/eid1606.100080
ajlm-1017	www.cdc.gov	https://www.cdc.gov/vhf/lassa/index.html
ajlm-1017	www.who.int	http://www.who.int/csr/disease/lassafever/en/
ajlm-1017	doi.org	https://doi.org/10.1093/cid/civ792
ajlm-1017	doi.org	https://doi.org/10.1136/bmjgh-2018-001179
ajlm-1017	www.who.int	http://www.who.int/blueprint/en/
ajlm-1017	doi.org	https://doi.org/10.1586/14737159.2016.1142877
ajlm-1017	doi.org	https://doi.org/10.1128/jcm.01594-16
ajlm-1017	doi.org	https://doi.org/10.1016/s1473-3099(13)70250-0
ajlm-1017	doi.org	https://doi.org/10.1016/j.jcv.2017.01.006
ajlm-1017	doi.org	https://doi.org/10.1093/infdis/jis203
ajlm-1017	www.who.int	http://www.who.int/medical_devices/tpp_20180327_final.pdf
ajlm-1017	path.org	https://path.org/resources/developing-a-point-of-care-multiplexed-diagnostic-system-for-low-resource-settings-in-developing-countries
ajlm-1017	gcgh.grandchallenges.org	https://gcgh.grandchallenges.org/challenge/develop-technologies-allow-assessment-multiple-conditions-and-pathogens-point-care
ajlm-1017	unitaid.eu	https://unitaid.eu/assets/multi-disease-diagnostics-landscape-for-integrated-management-of-hiv-hcv-tb-and-other-coinfections-january-2018.pdf
ajlm-1017	doi.org	https://doi.org/10.1016/j.jcv.2018.03.005
ajlm-1017	doi.org	https://doi.org/10.1371/journal.pntd.0006135
ajlm-1017	www.who.int	https://www.who.int/emergencies/what-we-do/prevention-readiness/disease-commodity-packages/en/
ajlm-1017	www.who.int	http://www.who.int/emergencies/diseases/en
ajlm-1017	www.who.int	https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
ajlm-1017	doi.org	https://doi.org/10.1371/journal.ppat.1003467
ajlm-1017	doi.org	https://doi.org/10.1093/infdis/jiw246
ajlm-1017	doi.org	https://doi.org/10.1038/srep44778
ajlm-1017	doi.org	https://doi.org/10.1007/s10544-017-0209-9
ajlm-1017	doi.org	https://doi.org/10.1186/s12879-017-2382-0
ajlm-1017	doi.org	https://doi.org/10.7754/clin.lab.2018.180411
ajlm-1017	doi.org	https://doi.org/10.1155/2017/7320859
ajlm-1017	doi.org	https://doi.org/10.1099/jmm.0.046631-0
ajlm-1017	www.genomeweb.com	https://www.genomeweb.com/pcr/cdc-provides-test-protocol-novel-coronavirus-preps-kits-local-use
ajlm-1017	www.who.int	http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en
ajlm-1017	doi.org	https://doi.org/10.7448/ias.18.7.20770
ajlm-1017	www.finddx.org	https://www.finddx.org/news/find-pilots-partnership-based-business-model-outbreak-response-first-investment-new-epidemic-preparedness-strategy
ajlm-1017	www.blink-dx.com	https://www.blink-dx.com/our-model
ajlm-1017	www.genomeweb.com	https://www.genomeweb.com/business-news/speedx-labcorp-will-codevelop-mdx-tests
ajlm-1017	www.360dx.com	https://www.360dx.com/pcr/speedx-mycoplasma-genitalium-resistance-test-cepheid-system-receives-ce-ivd
ajlm-1017	doi.org	https://doi.org/10.1186/1478-4505-9-33
ajlm-1017	www.gavi.org	https://www.gavi.org/library/news/statements/2017/gavi--effective-and-fit-for-purpose-